- Home
- MSM vs ACLX Comparison
MSM vs ACLX Comparison
Compare MSM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- ACLX
- Stock Information
- Founded
- MSM 1941
- ACLX 2015
- Country
- MSM United States
- ACLX United States
- Employees
- MSM N/A
- ACLX N/A
- Industry
- MSM Industrial Machinery/Components
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- ACLX Health Care
- Exchange
- MSM Nasdaq
- ACLX Nasdaq
- Market Cap
- MSM 4.3B
- ACLX 3.3B
- IPO Year
- MSM 1995
- ACLX 2022
- Fundamental
- Price
- MSM $79.34
- ACLX $67.23
- Analyst Decision
- MSM Hold
- ACLX Strong Buy
- Analyst Count
- MSM 6
- ACLX 13
- Target Price
- MSM $83.80
- ACLX $110.82
- AVG Volume (30 Days)
- MSM 604.5K
- ACLX 646.7K
- Earning Date
- MSM 04-03-2025
- ACLX 05-08-2025
- Dividend Yield
- MSM 4.29%
- ACLX N/A
- EPS Growth
- MSM N/A
- ACLX N/A
- EPS
- MSM 4.19
- ACLX N/A
- Revenue
- MSM $3,795,466,000.00
- ACLX $107,936,000.00
- Revenue This Year
- MSM N/A
- ACLX N/A
- Revenue Next Year
- MSM $4.42
- ACLX $107.10
- P/E Ratio
- MSM $18.93
- ACLX N/A
- Revenue Growth
- MSM N/A
- ACLX N/A
- 52 Week Low
- MSM $72.79
- ACLX $47.88
- 52 Week High
- MSM $96.13
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- MSM 51.39
- ACLX 48.28
- Support Level
- MSM $76.02
- ACLX $68.56
- Resistance Level
- MSM $80.76
- ACLX $72.68
- Average True Range (ATR)
- MSM 1.85
- ACLX 3.60
- MACD
- MSM 0.11
- ACLX -0.84
- Stochastic Oscillator
- MSM 75.60
- ACLX 56.93
Stock Price Comparison Chart: MSM vs ACLX
About MSM MSC Industrial Direct Company Inc.
MSC Industrial Direct is one of the largest industrial distributors with a focus on metalworking and maintenance, repair, and operations products and services. The company offers over 2 million products through its distribution network, which has 14 fulfillment or regional inventory centers. Although MSC has a presence in Canada, Mexico, and the United Kingdom, it primarily operates in the United States. In fiscal 2024, 95% of the firm's $3.8 billion of sales was generated in the US.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.